Clinical trial PM1183-B-005-14
A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | PharmaMar |
| EudraCT Identifier | 2014-003773-42 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02454972 |
| Inclusion criteria | brca 1/2 |
| Last update |